The antiviral drug "Ingavirin" refers to innovative medicines that have an effective therapeutic effect. Due to the unique formula, the mechanism of action on viral particles, the absence of side effects and a wide range of antiviral activity, this agent, when used in a timely manner, can significantly reduce the severity of the symptoms of viral etiology, preventing the development of serious complications.
Starting taking the antiviral drug Ingavirin in the first two days after detecting the symptoms of the disease significantly helps to ease the catarrh, fever, the effects of intoxication and generally reduces the viral load. Despite the low degree of toxicity of the drug (it belongs to the fourth class of low toxic substances), it should be used for therapeutic purposes strictly following the recommendations specified in the instructions.
Description of the drug
The antiviral agent Ingavirin is a drug that is very popular among the population. According to the manufacturer, this tool is very effective and absolutely safe. It is convenient to use and very easy to dose. The drug has an affordable price, and it can also be bought at a pharmacy without a doctor’s prescription. In addition, it helps not only with flu, but also with infections affecting the respiratory tract.
Ingavirin is a medicine whose popularity is gaining momentum. This is a good antiviral drug that can be successfully used in the treatment of various respiratory tract infections. Respiratory diseases are very common among the population, and therefore the demand for drugs from this group is always very high.
Forms of drug release
The antiviral agent Ingavirin is available in the form of capsules, which differ in the number of active ingredients. In order to protect against accidental replacement and falsification, the capsules are marked with a special symbol - the letter “I” in the ring.
Inside the medicine contains a white powder. The manufacturer allows the formation of lumps from the contents of the capsules, which does not affect the effectiveness of Ingavirin and is easily eliminated by lightly pressing the sides of the capsules. It must be remembered that the tablet form of this drug is not available on the pharmacological market.
For the correct and safe selection of dosing, the drug is available in various versions:
- In the form of blue capsules of 30 mg placed in contour cell blisters. They are placed in a cardboard box. Only one or two blisters, each of which has seven capsules.
- In the form of yellow capsules of 60 mg. The package contains one cell blister, in which seven capsules are placed.
- In the form of red capsules. The antiviral agent Ingavirin 90 mg is available in the same form as 60 mg.
The drug is also available in packages that are plastic jars in which capsules are placed. Their number can be from 60 to 90 pieces. This form of packaging is intended for therapy in a hospital, so it does not go on sale.
The composition of the drug
The antiviral drug Ingavirin contains the main active substance and auxiliary components. The first is the imidazolylethanamide pentanedioic acid. Depending on the dosage, its content in one capsule can be 30, 60 or 90 mg.
Additional components include compounds that are available for the production of the capsule itself. The shell is made from silicon dioxide, magnesium stearate, starch and lactose. Propylene glycol, dyes and titanium dioxide in small quantities are used for coloring and labeling of the capsule.
What diseases is this remedy prescribed for?
The antiviral drug Ingavirin in small and medium doses is prescribed for the treatment of children from seven years. Also, a medicament with a content of 30 and 60 mg of the active substance can be used for prophylactic purposes, when there is a high probability of infection. For example, in contact with patients. In this case, it is allowed to use only by patients who have reached 18 years of age. Ingavirin 90 mg is intended for the treatment and prevention of diseases only in adults.
It has a pronounced effect on influenza viruses, parainfluenza pathogens, respiratory syncytial infections, adenoviruses and a number of other pathogenic microorganisms. The instructions for use provide recommendations for taking the antiviral tablets "Ingavirin" for the treatment and prevention of diseases exclusively of viral etiology.
Therapeutic effect of the drug
Given the timely use of the drug, one can expect this effect:
- suppression of the ability of viruses to reproduce, thereby reducing the severity of symptoms and the duration of the acute period of the disease;
- preventing the spread of viruses throughout the body;
- the body produces interferon and white blood cells;
- relieving inflammation and reducing the severity of fever, as well as its accompanying symptoms;
- prevention of complications.
Pharmacokinetics
According to the instructions for the antiviral drug Ingavirin, the use of a therapeutic dosage contributes to the accumulation of the active substance in the tissues within half an hour after administration. This drug is almost completely eliminated from the body in a day unchanged. If taken at the recommended dosage in the blood plasma, the study is not detected.
The process of drug excretion is carried out through the intestines. It is worth noting that up to 77% is thus derived. The remaining 23% is excreted by the body through the kidneys.
Dosage, age restrictions and instructions
The antiviral Ingavirin, regardless of the amount of active substance in one capsule, is taken once a day. During the entire course of treatment or prophylactic administration, it is recommended to adhere to one specific time of administration in order to ensure the greatest therapeutic or protective effect. The use of the drug does not depend on the diet and the meal time. Capsules need to be washed down with a large amount of liquid. They must be swallowed whole, not opened and not bitten.
The duration of the course intake for therapeutic and prophylactic purposes is the same, and ranges from five to seven days. The duration of the course and the appropriate dosage can be determined solely by the attending doctor, taking into account the individual characteristics of the patient's body, age, the presence of concomitant diseases and the course of infectious pathologies.
Influenza and respiratory viral infections in children aged seven to seventeen are treated with Ingavirin in a dosage of 60 mg (one 60 mg capsule or two 30 mg capsules).
A dosage of 90 mg is intended for the treatment and prevention of viral pathologies in adults. The effectiveness of this drug is ensured due to the early start of administration, which should occur no later than 36 hours after the onset of the first symptoms of a viral disease or from the moment when contact with the patient occurred. For prophylactic and therapeutic purposes, take one capsule per day for five days.
Contraindications to taking the medicine and its possible side effect
The drug "Ingavirin" is prohibited for use in early childhood. In addition, the possibility of increasing the daily dosage from 60 mg to 90 mg for children under the age of 18 is excluded.
Despite the absence of any data on the relative terratogenic and embryotoxic effects, as well as the negative effect on reproductive activity, this drug cannot be prescribed for administration during the gestation period because of the ability of the drug to activate the body's defenses, which, in turn, , can provoke the process of rejection of the fetus.
For the reason that a study was not conducted regarding the ability of the active substance to penetrate into breast milk and the probability of a negative effect on the baby’s body was not determined, the Ingavirin preparation is strictly contraindicated during lactation. If antiviral therapy is needed, breast-feeding is stopped for this time.
With great care, this remedy is prescribed for lactase deficiency, against the background of lactose intolerance, with sensitivity to the basic and related components of the drug. Side effects can be expressed as an allergic reaction.
Before use, you must carefully read the instructions for the antiviral drug Ingavirin. It is preliminary recommended to consult a physician.
Compatibility with other medicines and alcohol
In experiments, the increased effectiveness of Ingaverin in the treatment of bacterial and viral infections, with secondary pneumonia and bronchitis in combination therapy with antibacterial agents.
Studies on the interaction of this drug with ethanol have not been conducted, however, during treatment and prevention, it is recommended to refrain from drinks containing alcohol.
The antiviral drug Ingavirin does not have a sedative effect and does not have any effect on psychomotor reactions, and therefore it can be used while driving a car or during periods of work that requires increased coordination of movements and concentration.
Analogs
Medicines that contain the same active substance as Ingaverin are Vitaglutam and Dicarbamine. Their effects are based on a similar component.
Other antiviral drugs that have a wide range of effects against similar types of infectious agents should also be highlighted. These include Amiksin, Ribavirin, Tamiflu, Remantadin and many others. However, if there is a need to replace Ingavirin with a similar agent, it is imperative to consult with a specialist.
Antiviral drug for children "Ingavirin"
The use of the drug in pediatrics is allowed only if the child is already seven years old. To date, it has not been completely studied how the drug will affect the body of a young child, since there have been no relevant clinical studies. This means that the safety and effectiveness of this drug for children under seven years of age has not been confirmed by any medical study. Thus, this factor alone indicates that the antiviral Ingavirin should not be used for young children, since it is not known what consequences this could have for the child’s body.
In addition, it is necessary to know that the history of the drug is much longer than it might seem at first glance, and there are very serious factors in it that indicate the need to abandon the use of this drug in the treatment of infectious diseases in children. The fact is that the drug in question was registered and launched into the pharmaceutical market as an antiviral agent only ten years ago, and it was synthesized back in the seventies of the last century. After receiving this drug in the 70s, it was used as a stimulator of hematopoiesis in people who received chemotherapy to eliminate a malignant tumor. In principle, the drug in question is still used in oncological practice, though under a different name.
Thus, it is obvious that the antiviral agent Ingavirin can have an effect on blood formation processes, which can provoke extremely negative consequences for children. After all, the regulation system in children is not as perfect and stable as in adult patients, as a result of which even minimal interventions in their work can lead to negative consequences and the development of serious diseases. It is because of this potential danger that Ingavirin is not recommended for use in the treatment of influenza and acute respiratory viral infections among children under the age of 18 years. To treat babies, it is best to use safer analogues. For example, these are antiviral agents such as Arbidol and Anaferon.
Opinions of doctors and patients
Reviews about the antiviral Ingavirin are mixed. Half of them are positive, and the other part is negative.
Those people who respond positively about the drug, indicate in the comments that this antiviral agent significantly facilitates the course of influenza and otolaryngological diseases, and also helps to accelerate recovery and reduce the period of the disease to five days, as stated in the instructions.
In negative reviews, patients note that Ingaverin does not produce any noticeable effect during treatment, as a result of which the severity of symptoms and the duration of the disease are not reduced. Thus, we can conclude that the medication is not effective in all cases.
Also on the forums you can find reviews of doctors about the antiviral Ingavirin. Here the situation is the same: someone writes good comments about him, and someone writes bad ones. Doctors point out that after the start of taking the drug, the patient’s blood pressure rises sharply, which is then difficult to normalize, as a result of which the patient has to go to a medical institution to stop the resulting hypertensive crisis. Specialists associate a similar effect of Ingavirin, primarily with its negative effect on the kidneys. As a result, urine excretion slows down and, accordingly, a sharp increase in pressure occurs against this background.
In this regard, people who suffer from some kind of kidney disease need to be careful when taking "Ingavirin". You should also pay attention to blood pressure, periodically measuring it. In the event that it rises sharply, you should immediately stop using the medication and seek help from a specialized medical institution.
The instructions for the antiviral drug Ingavirin were presented above, the rules for admission and reviews were reviewed, based on which you can decide whether to buy this drug.